勃林格殷格翰的能倍乐多少钱一盒？

It works 24 hours a day, so only use it once a day, and if possible, at the same time every day. Spray twice with each use. It should be noted that patients should not overdose to avoid harm to the body. Normal use of Respimat can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life. So, how much does a box of Boehringer Ingelheim’s Respimat cost?

Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry and animal health products. It is also the world's largest privately held pharmaceutical company. Boehringer Ingelheim's main research areas include: immune and respiratory diseases, cardiovascular and metabolic diseases, central nervous system diseases, and tumors. Boehringer Ingelheim has a complete biopharmaceutical industry chain, from genetic engineering of cells to manufacturing, and commercial production of off-the-shelf medicines for external industrial customers.

Respimat has been on the market in China since 2014, so patients only need to rely on pharmacies to buy Respimat at major domestic pharmacies. In addition, Respimat has been included in Category B of medical insurance, but the reimbursement standards of medical insurance vary from place to place.

Compared with the domestic price, it is still relatively expensive. It is understood that the current relatively low price of Respimat is about 170 US dollars per box. Patients in need can buy it abroad or obtain the medicine through domestic professional overseas medical service organizations (such as Medical Companion Travel), and have it shipped directly to their homes, ensuring authenticity.

Because adult chronic obstructive pulmonary disease (COPD) is a long-term condition, use Respimat every day, not just when you have breathing problems. Do not exceed recommended dosage. Slivar Respimat is a once-daily maintenance bronchodilator and cannot be used as a rescue treatment for acute episodes of bronchospasm.

It has good effects and high safety. It has been approved for marketing in my country in 2014, bringing new and effective options for the treatment of domestic patients with chronic obstructive pulmonary disease.